Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability

Details for Australian Patent Application No. 2004255022 (hide)

Owner AstraZeneca AB

Inventors Ryan, Anderson Joseph; Wedge, Stephen Robert

Agent Davies Collison Cave

Pub. Number AU-B-2004255022

PCT Pub. Number WO2005/004870

Priority 0407753.3 06.04.04 GB; 0406546.2 24.03.04 GB; 0316176.7 10.07.03 GB

Filing date 7 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 23 August 2007

International Classifications

A61K 31/282 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004870 Priority application(s): WO2005/004870

23 August 2007 Application Accepted

  Published as AU-B-2004255022

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255023-Combination therapy

2004255018-Controlling apparatus of an electric oven and controllig method of the same